These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33972171)

  • 1. Phenotypic diversity of brain MRI patterns in mitochondrial aminoacyl-tRNA synthetase mutations.
    Roux CJ; Barcia G; Schiff M; Sissler M; Levy R; Dangouloff-Ros V; Desguerre I; Edvardson S; Elpeleg O; Rötig A; Munnich A; Boddaert N
    Mol Genet Metab; 2021 Jun; 133(2):222-229. PubMed ID: 33972171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FARS2 deficiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance.
    Almannai M; Wang J; Dai H; El-Hattab AW; Faqeih EA; Saleh MA; Al Asmari A; Alwadei AH; Aljadhai YI; AlHashem A; Tabarki B; Lines MA; Grange DK; Benini R; Alsaman AS; Mahmoud A; Katsonis P; Lichtarge O; Wong LC
    Mol Genet Metab; 2018 Nov; 125(3):281-291. PubMed ID: 30177229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination.
    Fine AS; Nemeth CL; Kaufman ML; Fatemi A
    J Neurodev Disord; 2019 Dec; 11(1):29. PubMed ID: 31839000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in aARS genes revealed by targeted next-generation sequencing in patients with mitochondrial diseases.
    Felhi R; Charif M; Sfaihi L; Mkaouar-Rebai E; Desquiret-Dumas V; Kallel R; Bris C; Goudenège D; Guichet A; Bonneau D; Procaccio V; Reynier P; Amati-Bonneau P; Hachicha M; Fakhfakh F; Lenaers G
    Mol Biol Rep; 2020 May; 47(5):3779-3787. PubMed ID: 32319008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the phenotype of FARS2 deficiency.
    Vantroys E; Larson A; Friederich M; Knight K; Swanson MA; Powell CA; Smet J; Vergult S; De Paepe B; Seneca S; Roeyers H; Menten B; Minczuk M; Vanlander A; Van Hove J; Van Coster R
    Mol Genet Metab; 2017 Dec; 122(4):172-181. PubMed ID: 29126765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency.
    Almalki A; Alston CL; Parker A; Simonic I; Mehta SG; He L; Reza M; Oliveira JM; Lightowlers RN; McFarland R; Taylor RW; Chrzanowska-Lightowlers ZM
    Biochim Biophys Acta; 2014 Jan; 1842(1):56-64. PubMed ID: 24161539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease.
    Zadjali F; Al-Yahyaee A; Al-Nabhani M; Al-Mubaihsi S; Gujjar A; Raniga S; Al-Maawali A
    Hum Mutat; 2018 Oct; 39(10):1355-1359. PubMed ID: 30014610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment and characterization of the mRNAs of four aminoacyl-tRNA synthetases from yeast.
    Sellami M; Rether B; Gangloff J; Ebel JP; Bonnet J
    Nucleic Acids Res; 1983 May; 11(10):3269-82. PubMed ID: 6344009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2.
    Glamuzina E; Brown R; Hogarth K; Saunders D; Russell-Eggitt I; Pitt M; de Sousa C; Rahman S; Brown G; Grunewald S
    J Inherit Metab Dis; 2012 May; 35(3):459-67. PubMed ID: 22086604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three human aminoacyl-tRNA synthetases have distinct sub-mitochondrial localizations that are unaffected by disease-associated mutations.
    González-Serrano LE; Karim L; Pierre F; Schwenzer H; Rötig A; Munnich A; Sissler M
    J Biol Chem; 2018 Aug; 293(35):13604-13615. PubMed ID: 30006346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypes and genotypes of mitochondrial aminoacyl-tRNA synthetase deficiencies from a single neurometabolic clinic.
    Al Balushi A; Matviychuk D; Jobling R; Salomons GS; Blaser S; Mercimek-Andrews S
    JIMD Rep; 2020 Jan; 51(1):3-10. PubMed ID: 32071833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy.
    Elo JM; Yadavalli SS; Euro L; Isohanni P; Götz A; Carroll CJ; Valanne L; Alkuraya FS; Uusimaa J; Paetau A; Caruso EM; Pihko H; Ibba M; Tyynismaa H; Suomalainen A
    Hum Mol Genet; 2012 Oct; 21(20):4521-9. PubMed ID: 22833457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Mitochondrial Phenylalanyl-tRNa-Synthetase Deficiency (FARS2) with Oral Phenylalanine.
    Oswald SL; Steinbrücker K; Achleitner MT; Göschl E; Bittner RE; Schmidt WM; Tiefenthaler E; Hammerl E; Eisl A; Mayr D; Mayr JA; Wortmann SB
    Neuropediatrics; 2023 Oct; 54(5):351-355. PubMed ID: 36603837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic impact of pathogenic variants in the mitochondrial glutamyl-tRNA synthetase EARS2.
    Ni M; Black LF; Pan C; Vu H; Pei J; Ko B; Cai L; Solmonson A; Yang C; Nugent KM; Grishin NV; Xing C; Roeder E; DeBerardinis RJ
    J Inherit Metab Dis; 2021 Jul; 44(4):949-960. PubMed ID: 33855712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation in yeast of novel variants in mitochondrial aminoacyl-tRNA synthetases WARS2, NARS2, and RARS2 genes associated with mitochondrial diseases.
    Figuccia S; Izzo R; Legati A; Nasca A; Goffrini P; Ghezzi D; Ceccatelli Berti C
    Hum Mol Genet; 2024 Sep; 33(18):1630-1641. PubMed ID: 39230874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy.
    van Berge L; Hamilton EM; Linnankivi T; Uziel G; Steenweg ME; Isohanni P; Wolf NI; Krägeloh-Mann I; Brautaset NJ; Andrews PI; de Jong BA; al Ghamdi M; van Wieringen WN; Tannous BA; Hulleman E; Würdinger T; van Berkel CG; Polder E; Abbink TE; Struys EA; Scheper GC; van der Knaap MS;
    Brain; 2014 Apr; 137(Pt 4):1019-29. PubMed ID: 24566671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Cases of Non-Syndromic Hearing Impairment Caused by Pathogenic Variants in Genes Encoding Mitochondrial Aminoacyl-tRNA Synthetases.
    Domínguez-Ruiz M; Olarte M; Onecha E; García-Vaquero I; Gelvez N; López G; Villamar M; Morín M; Moreno-Pelayo MA; Morales-Angulo C; Polo R; Tamayo ML; Del Castillo I
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel (ovario) leukodystrophy related to AARS2 mutations.
    Dallabona C; Diodato D; Kevelam SH; Haack TB; Wong LJ; Salomons GS; Baruffini E; Melchionda L; Mariotti C; Strom TM; Meitinger T; Prokisch H; Chapman K; Colley A; Rocha H; Ounap K; Schiffmann R; Salsano E; Savoiardo M; Hamilton EM; Abbink TE; Wolf NI; Ferrero I; Lamperti C; Zeviani M; Vanderver A; Ghezzi D; van der Knaap MS
    Neurology; 2014 Jun; 82(23):2063-71. PubMed ID: 24808023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations.
    Ciara E; Rokicki D; Lazniewski M; Mierzewska H; Jurkiewicz E; Bekiesińska-Figatowska M; Piekutowska-Abramczuk D; Iwanicka-Pronicka K; Szymańska E; Stawiński P; Kosińska J; Pollak A; Pronicki M; Plewczyński D; Płoski R; Pronicka E
    J Hum Genet; 2018 Apr; 63(4):473-485. PubMed ID: 29410512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Compound Heterozygous Mutations Expand the Recognized Phenotypes of FARS2-Linked Disease.
    Walker MA; Mohler KP; Hopkins KW; Oakley DH; Sweetser DA; Ibba M; Frosch MP; Thibert RL
    J Child Neurol; 2016 Aug; 31(9):1127-37. PubMed ID: 27095821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.